NCT00010413 Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus Status COMPLETED Phase PHASE2
NCT00010400 Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome Status COMPLETED Phase NA
NCT00010387 Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease Status COMPLETED Phase PHASE2
NCT00009997 Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00008203 Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer Status COMPLETED Phase PHASE3
NCT00008190 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia Status COMPLETED Phase PHASE2
NCT00008034 Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer Status COMPLETED Phase PHASE1
NCT00008008 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE2
NCT00007995 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis Status COMPLETED Phase PHASE2
NCT00007982 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer Status COMPLETED Phase PHASE2
NCT00007904 Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes Status COMPLETED Phase PHASE2
NCT00007813 Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT00007475 Permeability Factor in Focal Segmental Glomerulosclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT00006734 Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor Status COMPLETED Phase PHASE3
NCT00006721 S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00006669 Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma Status WITHDRAWN Phase PHASE2
NCT00006461 Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor Status COMPLETED Phase PHASE3
NCT00006455 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) Status COMPLETED Phase PHASE3
NCT00006451 Bone Marrow Transplantation in Treating Patients With Leukemia Status WITHDRAWN Phase PHASE3
NCT00006390 Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2